Hydrogen sulfide: Regulatory role on blood pressure in hyperhomocysteinemia

Vascular Pharmacology

Volumn 53, Issue 3-4, 2010, Pages 138-143

  Sowmya, Sagiraju ^a   Swathi, Yada ^a   Yeo, Ai Ling ^a   Shoon, Mei Leng ^a   Moore, Philip Keith ^a,b   Bhatia, Madhav ^a,c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Blood pressure; Homocysteine; Hydrogen sulfide; Methionine; Sodium nitroprusside

Indexed keywords

ACETYLCHOLINE; HOMOCYSTEINE; HYDROGEN SULFIDE; KETAMINE; MEDETOMIDINE; METHIONINE; N(G) NITROARGININE METHYL ESTER; NITROPRUSSIDE SODIUM; NORADRENALIN; PROPARGYLGLYCINE; SODIUM HYDROGEN SULFIDE; SULFIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY CATHETERIZATION; ARTICLE; BLOOD PRESSURE; CAROTID ARTERY; CONTROLLED STUDY; HYPERHOMOCYSTEINEMIA; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BLOOD PRESSURE; HOMOCYSTEINE; HYDROGEN SULFIDE; HYPERHOMOCYSTEINEMIA; MALE; METHIONINE; NG-NITROARGININE METHYL ESTER; NITROPRUSSIDE; RATS; RATS, SPRAGUE-DAWLEY; SULFIDES;

EID: 77956186260     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2010.05.004     Document Type: Article

References (49)

1. Adnot S., Raffestin B., Eddahibi S. NO in the lung. Respir. Physiol. 1995, 101:109.
2. Aguilar B., Rojas J.C., Collados M.T. Metabolism of homocysteine and its relationship with cardiovascular disease. J. Thromb. Thrombolysis 2004, 18:75.
3. Ali M.Y., Ping C.Y., Mok Y.Y., Ling L., Whiteman M., Bhatia M., Moore P.K. Regulation of vascular nitric oxide in vitro and in vivo; a new role for endogenous hydrogen sulphide?. Br. J. Pharmacol. 2006, 149:625.
4. Bagi Z., Cseko C., Toth E., Koller A. Oxidative stress-induced dysregulation of arteriolar wall shear stress and blood pressure in hyperhomocysteinemia is prevented by chronic vitamin C treatment. Am. J. Physiol. Heart Circ. Physiol. 2003, 285:H2277.
5. Bellamy M.F., McDowell I.F., Ramsey M.W., Brownlee M., Bones C., Newcombe R.G., Lewis M.J. Hyperhomocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults. Circulation 1998, 98:1848.
6. Budak N., Yazici C., Ozturk A., Bayram F., Mazicioglu M.M., Kurtoglu S. Is plasma homocysteine level associated with metabolic syndrome components in adolescents?. Metab. Syndr. Relat. Disord. 2009, 7(4):357-362.
7. Cerdan C., Bhatia M. Novel roles for Notch, Wnt and Hedgehog in hematopoesis derived from human pluripotent stem cells. Int. J. Dev. Biol. 2010, 54:955-963.
8. Chan S.H., Wu K.L., Kung P.S., Chan J.Y. Oral intake of rosiglitazone promotes a central antihypertensive effect via upregulation of peroxisome proliferator-activated receptor-{gamma} and alleviation of oxidative stress in rostral ventrolateral medulla of spontaneously hypertensive rats. Hypertension. 2010, 55:1444-1453.
9. Chang L., Geng B., Yu F., Zhao J., Jiang H., Du J., Tang C. Hydrogen sulfide inhibits myocardial injury induced by homocysteine in rats. Amino Acids 2008, 34:573.
10. Chen L., Ingrid S., Ding Y.G., Liu Y., Qi J.G., Tang C.S., Du J.B. Imbalance of endogenous homocysteine and hydrogen sulfide metabolic pathway in essential hypertensive children. Chin. Med. J. (Engl.) 2007, 120:389.
11. Fukada S., Morita T., Sugiyama K. Effects of various amino acids on methionine-induced hyperhomocysteinemia in rats. Biosci. Biotechnol. Biochem. 2008, 72:1940.
12. Garg U.C., Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest. 1989, 83:1774.
13. Guo Y.H., Chen F.Y., Wang G.S., Chen L., Gao W. Diet-induced hyperhomocysteinemia exacerbates vascular reverse remodeling of balloon-injured arteries in rat. Chin. Med. J. (Engl.) 2008, 121:2265.
14. Heinecke J.W., Rosen H., Suzuki L.A., Chait A. The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. J. Biol. Chem. 1987, 262:10098.
15. Hosoki R., Matsuki N., Kimura H. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem. Biophys. Res. Commun. 1997, 237:527.
16. Johansen D., Ytrehus K., Baxter G.F. Exogenous hydrogen sulfide (H2S) protects against regional myocardial ischemia-reperfusion injury-evidence for a role of K ATP channels. Basic Res. Cardiol. 2006, 101:53.
17. Kuszczyk M., Gordon-Krajcer W., Lazarewicz J.W. Homocysteine-induced acute excitotoxicity in cerebellar granule cells in vitro is accompanied by PP2A-mediated dephosphorylation of tau. Neurochem. Int. 2009, 55:174.
18. Lentz S.R. Homocysteine and vascular dysfunction. Life Sci. 1997, 61:1205.
19. Li L., Bhatia M., Zhu Y.Z., Zhu Y.C., Ramnath R.D., Wang Z.J., Anuar F.B., Whiteman M., Salto-Tellez M., Moore P.K. Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. FASEB J. 2005, 19:1196.
20. Li Y.F., Xiao C.S., Hui R.T. Calcium sulfide (CaS), a donor of hydrogen sulfide (H(2)S): a new antihypertensive drug?. Med. Hypotheses 2009, 73:445.
21. Mattson M.P., Shea T.B. Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci. 2003, 26:137.
22. McDowell I.F., Lang D. Homocysteine and endothelial dysfunction: a link with cardiovascular disease. J. Nutr. 2000, 130:369S.
23. Miller J.W., Nadeau M.R., Smith D., Selhub J. Vitamin B-6 deficiency vs folate deficiency: comparison of responses to methionine loading in rats. Am. J. Clin. Nutr. 1994, 59:1033.
24. Musolino R., La Spina P., Granata A., Gallitto G., Leggiadro N., Carerj S., Manganaro A., Tripodi F., Epifanio A., Gangemi S., Di Perri R. Ischaemic stroke in young people: a prospective and long-term follow-up study. Cerebrovasc. Dis. 2003, 15:121.
25. Palmer R.M., Ashton D.S., Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988, 333:664.
26. Pan T.T., Feng Z.N., Lee S.W., Moore P.K., Bian J.S. Endogenous hydrogen sulfide contributes to the cardioprotection by metabolic inhibition preconditioning in the rat ventricular myocytes. J. Mol. Cell. Cardiol. 2006, 40:119.
27. Patel P., Vatish M., Heptinstall J., Wang R., Carson R.J. The endogenous production of hydrogen sulphide in intrauterine tissues. Reprod. Biol. Endocrinol. 2009, 7:10.
28. Pexa A., Boeger R.H., Henle T., Schwedhelm E., Deussen A. Effects of moderate hyperhomocysteinaemia induced by 4weeks methionine-enriched diet on metabolite profile and mesenteric artery function in rats. Br. J. Nutr. 2008, 99:993.
29. Rodrigo R., Passalacqua W., Araya J., Orellana M., Rivera G. Homocysteine and essential hypertension. J. Clin. Pharmacol. 2003, 43:1299.
30. Sharma M., Rai S.K., Tiwari R.K., Tiwari M., Chandra R. Effects of nitric oxide modulators on cardiovascular risk factors in mild hyperhomocysteinaemic rat model. Basic Clin. Pharmacol. Toxicol. 2008, 103:25.
31. Shirhan M., Moochhala S.M., Kerwin S.Y., Ng K.C., Lu J. Influence of selective nitric oxide synthetase inhibitor for treatment of refractory haemorrhagic shock. Resuscitation 2004, 61:221.
32. Splaver A., Lamas G.A., Hennekens C.H. Homocysteine and cardiovascular disease: biological mechanisms, observational epidemiology, and the need for randomized trials. Am. Heart J. 2004, 148:34.
33. Stipanuk M.H., Beck P.W. Characterization of the enzymic capacity for cysteine desulphhydration in liver and kidney of the rat. Biochem. J. 1982, 206:267.
34. Sun N.L., Xi Y., Yang S.N., Ma Z., Tang C.S. Plasma hydrogen sulfide and homocysteine levels in hypertensive patients with different blood pressure levels and complications. Zhonghua Xin Xue Guan Bing Za Zhi 2007, 35:1145.
35. Swaroop M., Bradley K., Ohura T., Tahara T., Roper M.D., Rosenberg L.E., Kraus J.P. Rat cystathionine beta-synthase. Gene organization and alternative splicing. J. Biol. Chem. 1992, 267:11455.
36. Szabo K., Kern R., Hennerici M.G. Recent advances in imaging in management of symptomatic internal carotid artery disease. Int. J. Stroke 2007, 2:97.
37. Tang C., Li X., Du J. Hydrogen sulfide as a new endogenous gaseous transmitter in the cardiovascular system. Curr. Vasc. Pharmacol. 2006, 4:17.
38. Tyagi N., Moshal K.S., Sen U., Vacek T.P., Kumar M., Hughes W.M., Kundu S., Tyagi S.C. H2S protects against methionine-induced oxidative stress in brain endothelial cells. Antioxid. Redox Signal. 2009, 11:25.
39. Wagner C.A. Hydrogen sulfide: a new gaseous signal molecule and blood pressure regulator. J. Nephrol. 2009, 22:173.
40. Wang R. Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter?. FASEB J. 2002, 16:1792.
41. Wang R. The gasotransmitter role of hydrogen sulfide. Antioxid. Redox Signal. 2003, 5:493.
42. Wang X.B., Jin H.F., Tang C.S., Du J.B. Significance of endogenous sulfur-containing gases in the cardiovascular system. Clin. Exp. Pharmacol. Physiol. 2009, 2009 Jun 29. [Epub ahead of print].
43. Whiteman M., Moore P.K. Hydrogen sulfide and the vasculature: a novel vasculoprotective entity and regulator of nitric oxide bioavailability?. J. Cell. Mol. Med. 2009, 13:488.
44. Xiaohui L., Junbao D., Lin S., Jian L., Xiuying T., Jianguang Q., Bing W., Hongfang J., Chaoshu T. Down-regulation of endogenous hydrogen sulfide pathway in pulmonary hypertension and pulmonary vascular structural remodeling induced by high pulmonary blood flow in rats. Circ. J. 2005, 69:1418.
45. Yan H., Du J., Tang C. The possible role of hydrogen sulfide on the pathogenesis of spontaneous hypertension in rats. Biochem. Biophys. Res. Commun. 2004, 313:22.
46. Yan H., Du J.B., Tang C.S. Changes and significance of hydrogen sulfide/cystathionine gamma-lyase system in hypertension: an experimental study with rats. Zhonghua Yi Xue Za Zhi 2004, 84:1114.
47. Yang G., Wu L., Jiang B., Yang W., Qi J., Cao K., Meng Q., Mustafa A.K., Mu W., Zhang S., Snyder S.H., Wang R. H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science 2008, 322:587.
48. Zhao W., Wang R. H(2)S-induced vasorelaxation and underlying cellular and molecular mechanisms. Am. J. Physiol. Heart Circ. Physiol. 2002, 283:H474.
49. Zhao W., Zhang J., Lu Y., Wang R. The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. EMBO J. 2001, 20:6008.